Introduction
============

Ventricular tachycardia (VT), a life-threatening fast heart rhythm, occurs frequently in patients with myocardial infarction, and leading to sudden cardiac death. Although increased utilization of pre-procedural imaging ([@B18]), high-density mapping ([@B2]), epicardial access ([@B12]), and more extensive ablation strategies ([@B16]; [@B21]) have all contributed to improved procedure outcome, a high efficacy of treatment for VT in the electrophysiology (EP) laboratory has not yet been achieved. At present, catheter ablation is the most effective method to eliminate VT, however, it only has modest success, 50--88% ([@B1]). This is the result of limitations in current techniques for mapping the electrical functioning of the heart and identifying the targets for VT ablation.

Computational modeling has emerged as a powerful platform for the non-invasive investigation of lethal heart rhythm disorders and their treatment ([@B6]; [@B26]; [@B19]; [@B22]; [@B30],[@B31]); it has been used for risk stratification in patients with myocardial infarction (MI) ([@B34]; [@B3]; [@B13]) and prediction of reentry location ([@B4]; [@B15]; [@B37]). Computational technology has also been recently developed to guide patient ablation (the Virtual-heart Arrhythmia Ablation Targeting, or VAAT), and even used prospectively, as a prove of feasibility of the approach, in a small number of patients ([@B28]). In these models, the personalized element is limited to information that is extracted from non-invasive late gadolinium-enhanced magnetic resonance imaging (LGE-MRI) scans, which is the patient-specific ventricular geometry, and the spatial distribution of infarcted-remodeled tissue. Cell- and tissue scale EP in these models, while reflecting the fact that the substrate in VT patients involves EP ventricular remodeling ([@B11]; [@B17]; [@B24]), is derived from an average human set of EP parameters (i.e., EP~avg~) to represent non-infarcted tissue and remodeled gray zone (GZ). Clearly, an ideal option would be to use personalized EP in each model, however acquisition of such information is invasive, in contrast to the VAAT approach, which offers a non-invasive prediction of the ablation targets. Thus, the ablation targets that are predicted to terminate VT in post-MI patients using the VAAT approach might have a level of uncertainty associated with the fact that pre-determined EP is used.

Similar issues had previously arisen in using patient-specific models of persistent atrial fibrillation (AF) in patients with fibrotic remodeling ([@B33]; [@B37]; [@B14]; [@B20]). As the intention is that such models be used in the future to predict the patient-specific targets for AF, in a series of papers we sought to assess the level of uncertainty in such predictions ([@B14]; [@B20]). Research in these studies demonstrated that while not always the same ablation targets are predicted under the examined variable EP conditions ([@B14]), the majority of the targets that were not predicted under the average EP conditions manifested themselves upon repeating the pacing protocol post-ablation ([@B20]).

While persistent AF in the fibrotic substrate and VT post-MI have very different arrhythmia dynamics, they both result from a combination of remodeled structural substrate interacting with a remodeled EP. Thus, in this study, we aimed to systematically assess the effect of changes in the electrophysiological parameter set on the induced VTs and predicted ablation targets in personalized models of post-MI patient hearts.

Materials and Methods {#s1}
=====================

Post-infarction Human Heart Models
----------------------------------

For this retrospective study, we used data from 5 patients who were referred for catheter ablation of VT; their MRI data are used for model reconstruction. Details regarding patient information and model construction can be found in our previous publication ([@B28]). Briefly, the myocardium boundaries were semi-automatically segmented and regions of gray zone (GZ), core scar, and non-infarcted tissue were segmented from LGE-MRI by means of signal thresholding ([@B3]; [@B13]). Tetrahedral meshes were constructed directly from the segmented images using a previously described approach ([@B29]), which uses the dual mesh of an octree applied directly to the segmented 3D image stacks. Fiber orientations in the mesh were assigned using a previously validated rule-based method ([@B5]). In order to be able to conduct this research in a tractable manner, as it involves a very large number of simulations (see below), we conducted simulations in the left ventricle (LV) only in all these 5 models. The rationale for this choice is based on the fact that human infarcts resulting in VT are typically located in the LV ([@B8]; [@B23]); the LV was also the location where all the clinical VTs in these patients were sustained.

Modeling Cell- and Tissue-Scale Variability of Ventricle
--------------------------------------------------------

Electrophysiology properties were assigned in the model as previously described ([@B28]). Briefly, the mathematical description of electrical conduction in cardiac tissue was based on the monodomain representation ([@B27]). Core scar was modeled as passive tissue. Non-infarcted tissue and GZ were assigned human ventricular myocyte action potential dynamics ([@B32]). The values of the non-infarcted tissue conductivities used in this study were 0.255 and 0.0775 S/m in the longitudinal and transverse directions, respectively. Tissue in the GZ region was characterized with a 90% decrease in transverse conductivity to reflect connexin-43 remodeling in the infarct border zone ([@B36]).

To establish baseline reentry dynamics in the absence of variability in the electrophysiological component of the infarcted substrate, we first conducted simulations under average human VT EP, as in previous studies ([@B3]; [@B13]). For brevity, these conditions are referred to as EP~avg~. We then ran simulations in ventricular models with the same geometric structure and infarcted tissue distribution to assess the effects of APD and CV variability. For simulations with APD variability, specific ionic currents were modified to achieve ±10% APD ([Figure 1A,B](#F1){ref-type="fig"}), while minimally altering other AP properties, including resting membrane potential \[V~m~\], AP amplitude, and restitution curve slope ([Figure 1C](#F1){ref-type="fig"}). To simplify ionic current parameters selection process, I~Kr~ and I~Ks~ were modified simultaneously in 10% increments from −90 to 300%, and the current values that resulted in APD closest to the target APD (i.e., ±10% or ±20% APD) in each case were used in this study ([Table 1](#T1){ref-type="table"}). For simulations with CV variability, the longitudinal and transverse components of the conductivity tensor were modified to achieve ±10% CV. To avoid biasing effects from the complex infarcted structure in ventricular models, CV values were calibrated by simulating wavefront propagation following stimulation of the center point in a slab model (6 cm × 6 cm × 2.7 mm) with uniform fiber orientations, and conductivity tensor values were adjusted until the desired longitudinal and transverse CVs were observed. In both families of cases (i.e., APD~±10%~ and CV~±10%~ conditions), parameter changes required to achieve the desired emergent property were different for non-infarcted and GZ tissues. Complete details about these changes and the resulting variability in APD and CV are presented in [Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, respectively.

![**(A)** Action potential (AP) traces for simulated normal (non-infarcted) (left) and GZ (right) ventricular myocytes, paced to steady-state (1000 stimuli at basic CL = 600 ms) under average human VT electrophysiology (EP~avg~) conditions, and with AP duration (APD~90~) variability (±10% and ±20%). **(B)** APD restitution relationships for the respective cell types shown in A. Fit lines obtained via exponential regression. **(C)** Plots showing APD restitution curve slope values for different diastolic intervals.](fphys-10-00628-g001){#F1}

###### 

Cell-scale electrophysiological model parameters modified to achieve ±10% and ±20% action potential duration (APD) in non-infarcted and GZ tissues.

                              Parameters changed   APD~target~ (ms)   APD~actual~ (ms)   Percentage of APD changed   APA (mV)   V~rest~ (mV)   
  --------------- ----------- -------------------- ------------------ ------------------ --------------------------- ---------- -------------- -------
  Non-infarcted   APD~−20%~   +80% I~Kr~           +80% I~Ks~         230.8              233.28                      −20.8%     126.3          −84.8
                  APD~−10%~   +30% I~Kr~           +30% I~Ks~         263.8              262.44                      −9.5%      126.1          −84.8
                  EP~avg~     ...                  ...                291.6              291.6                       ...        126.0          −84.7
                  APD~+10%~   −20% I~Kr~           −20% I~Ks~         315.9              320.76                      8.3%       126.0          −84.7
                  APD~+20%~   −40% I~Kr~           −40% I~Ks~         348.5              349.92                      19.5%      126.0          −84.6
  Gray zone       APD~−20%~   +80% I~Kr~           +80% I~Ks~         309.7              306.24                      −19.1%     110.1          −85.3
                  APD~−10%~   +30% I~Kr~           +30% I~Ks~         348.1              344.52                      −9.1%      109.9          −85.3
                  EP~avg~     ...                  ...                382.8              382.8                       ...        109.9          −85.2
                  APD~+10%~   −20% I~Kr~           −20% I~Ks~         409.4              421.08                      7.0%       109.3          −85.2
                  APD~+20%~   −30% I~Kr~           −30% I~Ks~         454.2              459.36                      18.7%      108.7          −85.1

"..." indicates no change. EP

avg

, average human VT electrophysiology; APA, action potential amplitude; V

rest

, resting membrane potential; I

Ks

, slow delayed rectifier potassium current; I

Kr

, rapid delayed rectifier potassium current. APD

90

was used to calculate APD. APD

target

: The target APD (±10% or ±20% APD). APD

actual

: It represents the actual value of APD (closest to the target) obtained by altering I

Kr

and I

Ks

simultaneously (see section "Materials and Methods).

###### 

Tissue-scale electrophysiological model parameters modified to achieve ±10% and ±25% longitudinal and transverse conduction velocities (*CV*~L~ and *CV*~T~, respectively) in non-fibrotic and fibrotic atrial tissues.

                             Parameters changed   CV~L~ (cm/s)   CV~T~ (cm/s)   CV~L~:CV~T~   
  --------------- ---------- -------------------- -------------- -------------- ------------- ------
  Non-infarcted   CV~−25%~   −47.6% σ~iL~         −47.6% σ~iT~   41.1           26.2          1.57
                  CV~−10%~   −22.2% σ~iL~         −22.1% σ~iT~   49.3           30.7          1.61
                  EP~avg~    ...                  ...            54.8           33.5          1.63
                  CV~+10%~   +28.5% σ~iL~         +28.1% σ~iT~   60.3           36.6          1.65
                  CV~+25%~   +86.4% σ~iL~         +86.5% σ~iT~   68.5           41.3          1.66
  Gray zone       CV~−25%~   −46.1% σ~iL~         −46.1% σ~iT~   32.6           15.3          2.13
                  CV~−10%~   −21.4% σ~iL~         −21.3% σ~iT~   39.1           17.5          2.23
                  EP~avg~    ...                  ...            43.4           18.8          2.42
                  CV~+10%~   +25.6% σ~iL~         +25.5% σ~iT~   47.7           20.0          2.39
                  CV~+25%~   +81.2% σ~iL~         +81.4% σ~iT~   54.6           21.9          2.49

"..." indicates no change. σ

iL

and σ

iT

, longitudinal and transverse conductivity tensor values; EP

avg

, average human VT electrophysiology.

As experimental measurements ([@B7]) have shown that APD and CV could vary in a larger range, we conducted additional simulations in two models only (for computational tractability) with APD~±20%~ and CV~±25%~, and in one model, with a combination of APD~±20%~ and CV~±25%~. The parameter changes were listed in [Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}. We chose APD~±20%~ instead of APD~±25%~ because APD~+25%~ resulted in longer APD than the upper limit of APD in experimental measurements (364 ms vs. 340 ms) ([@B7]).

Stimulation Protocol
--------------------

All simulations were performed using the software package CARP^[1](#fn01){ref-type="fn"}^ on a parallel computing platform ([@B35]). A programmed electrical stimulation protocol similar to standard clinical stimulation protocols was performed to examine the arrhythmogenic propensity of the post-MI ventricular models ([@B9]). All models were paced from 7 locations, optimized for maximum likelihood of VT induction, for 6 beats (S1) at a cycle length (CL) of 600 ms followed by a premature stimulus (S2) initially given at 90% of S1 CL. The timing between S1 and S2 was progressively shortened until reentry was induced. If reentry was not induced, a second premature stimulus (S3) was delivered after S2. If VT was still not induced, a third premature stimulus (S4) was delivered after S3. Three seconds of VT were simulated.

The smallest S1-S2 coupling interval was determined in the fowling way: Six stimulus of S1 (CL = 600 ms) were delivered; then S2 was given at 250 ms. If excitation was elicited, then we decreased S2 to 200 ms. If the excitation could propagate again, then we decreased S2 in 10 ms intervals until excitation could not be elicited. The S2 coupling interval was the last one that elicited excitation propagation. The same protocol was applied to determine the smallest S2-S3 and S3-S4 intervals. If reentry was induced after the S2 stimulus, then no addition stimulus was given.

Ablation Strategy
-----------------

First, the reentrant circuit was identified in all models with EP~avg~ through analysis of the 3D reentrant wave propagation. *In silico* ablation was performed by rendering the tissue in the narrowest region of the reentrant circuit \[typically a channel in the scar as in ([@B28])\] non-excitable. Each virtual ablation lesion was of radius in our simulation was 3.5 mm, which is similar to the clinical catheter size ([@B25]). The VT induction protocol was then repeated to establish that VT was no longer inducible in the ablated LV substrate. If a new VT arose in the post-ablation model, then the new VT circuit was analyzed and additional ablation targets were determined and implemented in the model, and the pacing protocol was repeated until VT was no longer inducible.

All simulations were then repeated in the family of models with EP~var~ (APD~±10%~ and CV~±10%~, 20 additional 3D LV models; 25 3D LV models in total for this study). For VTs induced in each of these models, if the reentry morphology was the same or similar to VT induced in the corresponding EP~avg~ model, the ablation lesion from the EP~avg~ model was applied to the same location in the EP~var~ model. By similar reentry morphology we refer to reentries that have the same wavefront conduction pathway, with the same critical conduction channels (or conduction isthmus), but could have different CL, and even different reentry direction. If VT in the EP~var~ model was terminated, the ablation lesions in EP~var~ and EP~avg~ models were considered "overlapping." If VT persisted in the EP~var~ model despite the ablation, then these two VTs were considered non-overlapping. Then ablation in the EP~avg~ model proceeded as described above. Finally, the number of ablation lesions was compared between EP~avg~ and EP~var~ models.

###### 

Summary of results for simulations conducted in EP~avg~ models.

  ID    \# reentries pre-ablation   \# reentries post-ablation   Extent of ablated tissue (%)
  ----- --------------------------- ---------------------------- ------------------------------
  P01   4                           1                            1.3
  P02   3                           0                            0.2
  P03   2                           0                            0.1
  P04   4                           0                            2.1
  P05   3                           0                            0.9

Results
=======

For simulations conducted under EP~avg~ conditions, rapid pacing induced sustained VTs in all 5 patient-specific ventricular models. [Table 3](#T3){ref-type="table"} summarized the results of simulations conducted in EP~avg~ models. A total of 16 distinct reentries were induced in five models under the EP~avg~ condition, and after ablation, only one new distinct reentry was induced. The average amount of ablated ventricular tissue under EP~avg~ condition was 0.92%. Before ablation, there were 2--4 different sustained VTs (3.2 ± 0.8) induced in each model, and the organizing centers of all 16 VTs perpetuated in distinct locations. Ablation, as described in Section "Materials and Methods," did not always render the remodeled substrate non-inducible for VT; in some cases, new VTs could arise. Specifically, after ablation, 4 patient models did not have emergent VTs, while 1 patient model had one emergent VT at a location different from those before ablation. The volume of the simulated ablation lesions that terminated the VTs, both original and emergent, in each model was 0.92 ± 0.83% of the total ventricular volume (min: 0.1%, max: 2.1%).

###### 

Summary of simulation results regarding the number of VTs obtained for the EP~avg~ and EP~var~ (APD~±10%~ and CV~±10%~) models with the 5 patient-specific ventricular geometries.

                                                                  Total number of VTs   Number of VTs in EP~avg~ models   Percentage of VTs in EP~var~ models that were also present in EP~avg~ (%) models (%)
  ----------------------------------------------- --------------- --------------------- --------------------------------- --------------------------------------------------------------------------------------
  \# of induced VTs in EP~avg~                    Pre- ablation   16                    --                                --
                                                  Post-ablation   17                    --                                --
  \# of induced VTs in APD~+10%~                  Pre- ablation   10                    10                                100
                                                  Post-ablation   10                    10                                100
  \# of induced VTs in APD~−10%~                  Pre- ablation   11                    9                                 81.8
                                                  Post-ablation   12                    10                                83.3
  \# of induced VTs in CV~+10%~                   Pre- ablation   9                     9                                 100
                                                  Post-ablation   9                     9                                 100
  \# of induced VTs in CV~−10%~                   Pre- ablation   20                    14                                70
                                                  Post-ablation   21                    16                                76.2
  \# of induced VTs in APD~+20%~^∗^               Pre- ablation   3                     3                                 100
                                                  Post-ablation   3                     3                                 100
  \# of induced VTs in APD~−20%~^∗^               Pre- ablation   3                     3                                 100
                                                  Post-ablation   4                     3                                 75
  \# of induced VTs in CV~+25%~^∗^                Pre- ablation   3                     3                                 100
                                                  Post-ablation   3                     3                                 100
  \# of induced VTs in CV~−25%~^∗^                Pre- ablation   6                     5                                 83.3
                                                  Post-ablation   7                     5                                 71.4
  \# of induced VTs in APD~+20%~ & CV~+25%~^∗∗^   Pre- ablation   0                     0                                 0
                                                  Post-ablation   0                     0                                 0
  \# of induced VTs in APD~−20%~ & CV~+25%~^∗∗^   Pre- ablation   0                     0                                 0
                                                  Post-ablation   0                     0                                 0
  \# of induced VTs in APD~+20%~ & CV~−25%~^∗∗^   Pre- ablation   1                     1                                 100
                                                  Post-ablation   1                     1                                 100
  \# of induced VTs in APD~−20%~ & CV~−25%~^∗∗^   Pre- ablation   3                     3                                 100
                                                  Post-ablation   4                     3                                 75

"Number of VTs in EP

avg

models" represents the number of reentry morphologies induced in each set of modified conditions with similar or same reentry morphologies induced under the EP

avg

condition. The last column in

Table 4

is calculated as "Number of VTs in EPavg models"/" Total number of VTs", which represents how many reentry morphologies induced under each of the modified condition corresponded to the reentry morphologies induced under EP

avg

.

∗

, only 2 models were used with this EP parameter set;

∗∗

, only 1 model was used with this EP parameter set.

Comprehensive summary data for the VTs induced in simulations conducted in all 5 ventricular models under the 5 different APD/CV~±10%~ conditions each (EP~avg~, APD~±10%~, and CV~±10%~) are provided in [Table 4](#T4){ref-type="table"} and [Supplementary Tables S1](#SM1){ref-type="supplementary-material"}--[S4](#SM1){ref-type="supplementary-material"}. Of all 25 3D LV models used in this study, VT could be induced in 24. The only model in which VT could not be induced is that of patient 2 with CV~+10%~ parameters. In terms of the total number of VTs, 22 unique VTs were induced in the 24 inducible models. Eight of the VTs were induced under all five electrophysiological conditions; these were for patients 1, 3, 4, and 5. The activation maps of these 8 VTs are shown in [Figure 2](#F2){ref-type="fig"} and [Supplementary Figures S1](#SM1){ref-type="supplementary-material"}--[S3](#SM1){ref-type="supplementary-material"}. The VT in model 2 that was induced under 4 of the 5 EP parameter sets (and not under the CV~+10~) is shown in [Figure 3](#F3){ref-type="fig"}. Of the 4 varied parameter sets (APD~±10%~ and CV~±10%~), APD~±10%~, and CV~+10%~ resulted in less VTs, while CV~−10%~ resulted in more VTs compared with the EP~avg~ conditions.

![Geometry and simulated activation maps and ablation lesions under average human VT EP~avg~ and variable APD/CV conditions for model 5. **(A)** Geometric model of the infarcted heart of patient model 5. **(B)** Ablation lesions for simulations with the 5 different parameter sets. **(C)** Highlighting two VT morphologies in which the same pacing sequence applied in the same model led to the initiation of VT driven by an RD in the same ventricular region, regardless of the variability in APD/CV. t~a~, activation time. The black areas in panel C for all figures are core scar -- there is no electrical activation there.](fphys-10-00628-g002){#F2}

![Geometry and simulated activation maps and ablation lesions under average human VT EP~avg~ and variable APD/CV conditions for model 2. **(A)** Geometric model of the infarcted heart of patient model 2. **(B)** Ablation lesions for simulations for the 13 different parameter sets. **(C)** Highlighting one VT morphology in which the same pacing sequence applied in the same model led to the initiation of VT driven by an RD in the same ventricular region, regardless of the variability in APD/CV. t~a~, activation time. The black areas in panel C for all figures represent core scar -- there is no electrical activation there.](fphys-10-00628-g003){#F3}

There were 10 distinct reentries induced in models with the APD~+10%~ parameter set before ablation, and all of them corresponded to VTs under EP~avg~ conditions ([Table 4](#T4){ref-type="table"} and [Supplementary Table S1](#SM1){ref-type="supplementary-material"}). There were no emergent reentries after ablation under these electrophysiological conditions. For the CV~+10%~ parameter set ([Table 4](#T4){ref-type="table"} and [Supplementary Table S3](#SM1){ref-type="supplementary-material"}), there were 9 distinct VTs induced before ablation, and they all also matched the VTs in EP~avg.~ Under the APD~−10%~ conditions ([Table 4](#T4){ref-type="table"} and [Supplementary Table S2](#SM1){ref-type="supplementary-material"}), there were 11 distinct VTs before ablation, and 9 of them corresponded to those under EP~avg~ conditions. Only for patient 2 there was one emergent VT after ablation, which was different from any VT under EP~avg~ conditions before and after ablation (the blue lesion in Panel B of [Figure 3](#F3){ref-type="fig"}). In patient 1, two reentries were new and different from any VT under EP~avg~ conditions before ablation, but one of them was induced under EP~avg~ conditions after ablation (Panel B in [Supplementary Figure S1](#SM1){ref-type="supplementary-material"}). Thus overall, for the APD~−10%~ parameter set, 10 out of 12 VTs had matching reentries under EP~avg~ conditions, while the remaining 2 VTs were new, and different from the reentries in EP~avg~.

For the CV~−10%~ parameter set ([Table 4](#T4){ref-type="table"} and [Supplementary Table S4](#SM1){ref-type="supplementary-material"}), there were 20 distinct VTs induced before ablation, and 14 of them had corresponding reentries under EP~avg~ conditions. After ablation, there was only one emergent VT in patient 2 (Panel B in [Figure 3](#F3){ref-type="fig"}), but 2 of the VTs induced before ablation were also induced under EP~avg~ conditions, so 16 out of 21 VTs in the CV~−10%~ parameter set models had matching VTs under EP~avg~ after ablation.

The results for one example model (patient 5) under all 5 EP parameter sets are shown in [Figure 2](#F2){ref-type="fig"}. There were 3 distinct VTs induced under EP~avg~, one located at the septum ([Figure 2C](#F2){ref-type="fig"}, Morphology 1 in EP~avg~), another one at the LV lateral wall ([Figure 2C](#F2){ref-type="fig"}, Morphology 2 in EP~avg~), and the third one located at the posterior wall (morphology not shown). For the APD~±10%~ and CV~±10%~ parameter sets, both resulted in two reentries being induced, which were located at the septum and the LV lateral wall. Under CV~−10%~ conditions, there were 5 distinct VTs induced, and 3 of them had matching reentries in EP~avg~ models (ablation lesions in Panel B of [Figure 2](#F2){ref-type="fig"}).

For the 2 VTs induced under all 5 conditions, the morphology and location were very similar for across all models. For morphology 1 (first row in [Figure 2C](#F2){ref-type="fig"}), the reentry was circular, with the only difference being the CL, which varied from 195 ms to 380 ms. After ablating the narrowest channel region in VT morphology 1, the reentry was terminated. After applying the ablation lesions from EP~avg~ to the other 4 conditions (light blue lesions on the left side of [Figure 2B](#F2){ref-type="fig"}), and the reentry at that region was terminated in all 4 conditions too. For morphology 2, the reentry was circular in all 5 conditions, but the conduction pathway in CV~−10%~ condition showed differences. Under EP~avg~, APD~±10%~ and CV~+10%~ conditions, there was only one conduction pathway, but under the CV~−10%~ condition, the reentry had two condition pathways, one of which, the one close to posterior wall, was the same under the other 4 conditions. After ablating the narrowest channel region in morphology 2 in EP~avg~, the reentry was terminated. Then applying the ablation lesion from EP~avg~ to the four other EP versions (light blue lesions on the right side of [Figure 2B](#F2){ref-type="fig"}), the reentry under APD~±10%~, and CV~+10%~ conditions was terminated. But applying the ablation lesions from EP~avg~ didn't terminate the reentry induced in CV~−10%.~ After ablating the narrowest parts of both conducting pathways under CV~−10%~ conditions, reentry was terminated (the light blue and blue on the right-most side of CV~−10%~ in [Figure 2B](#F2){ref-type="fig"}). The VTs induced at the posterior wall in EP~avg~ could not be induced under APD~±10%~ and CV~+10%~ conditions; the ablation lesion for that reentry is shown in purple in the first 3 panels of [Figure 2B](#F2){ref-type="fig"}. The 3 VTs induced in EP~avg~ were all induced in CV~−10%~ (light blue lesions in CV~−10%~ panel of [Figure 2B](#F2){ref-type="fig"}), but there were 2 new VTs induced in CV~−10%~, of which the 2 ablation lesions are shown as blue in the CV~−10%~ panel in [Figure 2B](#F2){ref-type="fig"}.

[Figure 3](#F3){ref-type="fig"} shows the results for another patient model (patient 2) for the 5 EP parameter sets. There were 3 VTs induced in EP~avg~, with two of them being on the anterior wall, and the third on septum. For CV~+10%~, there was no reentry induced, and this is the only model variant of all 25 model variants in 5 the patients in which no reentry could be induced. Before ablation, the models with APD~±10%~ parameters had only one reentry induced, on the anterior middle wall ([Figure 3C](#F3){ref-type="fig"}), and this reentry is similar to the one induced in EP~avg~ (first panel in [Figure 3C](#F3){ref-type="fig"}). In CV~−10%,~ there were 3 VTs induced, and two of them had matching reentries in EP~avg~. But the one on the middle anterior wall had minor differences compared to the corresponding one in EP~avg~: it had 2 conduction pathways (CV~−10%~ panel in [Figure 3C](#F3){ref-type="fig"}), with the pathway on the right matching the one in EP~avg~, but the left side was a new pathway. Applying the lesions determined from EP~avg~, the middle anterior wall VT could not be terminated in CV~−10%~ (light blue lesion in the CV~−10%~ panel of the first row in [Figure 3B](#F3){ref-type="fig"}), and an additional lesion had to be applied to narrowest portion of the left condition pathway in CV~−10%~ to terminate the reentry on the anterior middle wall (blue lesion in the CV~−10%~ panel of the first row in [Figure 3B](#F3){ref-type="fig"}). After ablation, no reentry could be induced in EP~avg~ and APD~+10%~, but in APD~−10%,~ a new VT emerged at the vicinity of the ablation lesion on the anterior wall; the condition pathway of this RD is very similar to the left side pathway of the VT induced in CV~−10%~. Applying the EP~avg~ ablation lesions to CV~−10%~ terminated the VT. In CV~−10%~ condition, after ablation, there was an emergent VT, which matched the VT on the left side of the anterior wall in EP~avg~; applying the ablation lesion from EP~avg~ terminated the emergent reentry in CV~−10%.~ Results of the study for the other 3 patients are shown in [Supplementary Figures S1](#SM1){ref-type="supplementary-material"}--[S3](#SM1){ref-type="supplementary-material"}. Vann diagrams summarizing the results of simulations for all above cases are presented in [Figure 4](#F4){ref-type="fig"}.

![Venn diagrams for each models under average human VT EP~avg~ and variable APD/CV conditions. Numbers represent the number of distinct reentries in each case.](fphys-10-00628-g004){#F4}

Next, we present results of simulations with the additional EP parameter sets (from the extended parameter range) in the limited number of models, as described in Section "Materials and Methods." Results from simulations with model 2 are presented in [Figure 3](#F3){ref-type="fig"}. Upon change of APD from +10% to +20% and from −10 to −20%, there was no difference in reentry morphology and reentry location. When changing CV from ±10 to ±25%, there was a difference between results for the CV~+10%~ and CV~+25%~ cases: no reentry was induced in CV~+10%~ simulations, and there was one reentry induced in CV~+25%~. There was no difference between the cases of CV~−10%~ and CV~−25%~. Results for model 3 and the same parameter range are presented in [Supplementary Figure S2](#SM1){ref-type="supplementary-material"}. For this model, there was no difference between results for the APD~±20%~ and CV~+25%~ conditions, but under the CV~−25%~ condition, one new reentry emerged (panel D of [Supplementary Figure S2](#SM1){ref-type="supplementary-material"}) that was not present for the other modified APD and CV cases. Thus, based on the simulation results for the 2 patients with APD~±20%~ and CV~±25%~, we conclude that APD changes within the range of ±20% had no additional effects on reentry location. Changing CV in the range (±25%) resulted in changes in reentry location only when CV was at the boundaries of that range. A Venn diagram of these results is provided in [Figure 4](#F4){ref-type="fig"}.

Finally we executed simulations in one model with a combination of parameter changes, as described in Section "Materials and Methods." Conducting simulations with model 2, the combinations of APD~+20%~ & CV~+25%~ and APD~−20%~ & CV~+25%~ conditions did not result in reentry. There were two reentries induced under the APD~+20%~ & CV~−25%~ condition, one of which corresponded to the reentry morphology in EP~avg~ (see [Figure 3](#F3){ref-type="fig"}), and the other one was a new VT morphology with respect to the EP~avg~ case. There were four VT morphologies induced in the APD~−20%~ & CV~−25%~ condition, 3 of which corresponded to EP~avg~, and one was new. The combined reduction/increase of CV and APD produced only one different VT morphology as compared to EP~avg~. This VT morphology was the same as the ones induced for cases where only APD or only CV was changed. Thus we conclude, based on the simulations in model 2, that combined reduction/increase of CV and APD within the range of ±20% or ±25% had no additional effects on VTs compared with only changing APD or CV.

Discussion
==========

In this study, we used computational models reconstructed from LGE-MRI scans of the infarcted ventricle of individuals with VT to assess the sensitivity of VT localization to variability in cell- and tissue-scale electrophysiological parameters. We showed that: (1) in simulations conducted with ±10% APD/CV, a subset of VTs (76.2--100%, depending on the EP parameter set) were observed in approximately the same locations as those in the EP~avg~ case; (2) EP~avg~ conditions resulted in more VTs (5--8) than in APD~±10%~ and CV~+10%~, and in less reentries than in CV~−10%~; (3) Emergent VTs were induced sometimes post-ablation, and the emergent reentries often matched the pre-ablation VTs in models with other parameter sets. (4) Where the VTs were robust to APD/CV variability, there were differences, as expected, in macroscopic arrhythmia features such as CL and total activation time.

About 53% (9/17) of the reentries that occurred in EP~avg~ were also induced in all other four parameter set models (±10% APD/CV), and the remainder of reentries were induced in at least one of the four parameter set models. Interestingly, all the reentries induced in APD~+10%~ and CV~+10%~ models had matching reentries in the EP~avg~ models. The models with EP~avg~ were more inducible than the APD~+10%~ and CV~+10%~ models, as the wavelength in the former case was smaller, allowing for more space for the reentry to propagate and be sustained. While there were new VTs induced in models with APD~−10%~ and CV~−10%~, more than 76% of the VTs occurred also in models with EP~avg~. The models with APD~−10%~ had a smaller number of induced VTs than the corresponding EP~avg~ models. A possible explanation for this finding is that APD in the EP~avg~ parameter set falls in the arrhythmogenesis susceptibility window of APD ([@B10]), where there is a unidirectional block of electrical conduction through a VT-sustaining channel. Upon further reduction of APD, the VT channel conducts bi-directionally, resulting in a smaller number of included reentries.

In the additional simulations with the extended range of APD and CV and their combination, the results with the combined reduction/increase of CV and APD were very similar, in terms of reentry location, and pathway to those when varying APD or CV independently. Furthermore, APD~±20%~ and CV~±25%~ cases had similar outcomes to those with APD~±10%~ and CV~±10%~. Thus, simulating only ±10% APD or ±10% CV changes may be sufficient in representing the results from simulations with larger electrophysiological parameters variations.

These findings present evidence that VT localization is fairly robust to electrophysiological variability, and that the distribution of the infarcted tissue (core scar and GZ) might play a dominant role in determining the location of infarct-related VTs. Our results suggest that EP~avg~ models identified most of the VT ablation targets that were consistently observed under different EP conditions. Nonetheless, there was a small subset of reentries that were observed only under EP~avg~ simulations. Furthermore, in some models, VTs only emerged upon APD and/or CV change, suggesting that there could be a small number of potential ablation targets that may not be revealed using the EP~avg~ parameter set. Furthermore, for reentries with the same morphology and location of the critical conduction isthmus (and thus the same ablation target) we observed differences in CL, total activation time and in rare cases, even direction of propagation. Finally, we demonstrated that majority of ablation targets that were not predicted under EP~avg~ conditions manifested themselves upon repeating the pacing protocol post-ablation, similar to the findings in modeling of ablation for persistent AF in patients with fibrotic remodeling ([@B20]).

The results shown in this paper differ from our atrial sensitivity analysis study ([@B14]) because the mechanism of reentry in VT and AF are different. In the atrial models, there is only non-fibrotic and fibrotic tissue (both are excitable tissues, but fibrotic tissue has modified EP). In contrast, in the ventricular models, there is additionally a core scar. Thus reentries in the atrial models had a larger functional component and their morphologies and locations could be affected, by somewhat larger degree, by changes in APD or CV. In infarct-related VT, most of the reentries were anchored to core scar or included conduction through channels, consistent with published data ([@B23]).

Patient-specific computational modeling of VT has been proposed as a new approach to non-invasively predict personalized VT ablation targets in post-MI patients ([@B28]). The present study demonstrates that simulations conducted under EP~avg~ conditions identified most of VTs that were consistently observed under multiple different EP conditions. The uncertainty in the post-MI VT ablation targets under EP~avg~ is further mitigated by the design of the pipeline for determining the optimal set of targets \[as in the VAAT approach ([@B28])\], where the protocol is repeated post-ablation with virtual targets incorporated, until the remodeled substrate is no longer capable of sustaining VT. This allows the protocol to reveal additional VTs under EP~avg~ that are not manifested following the initial pacing protocol prior to virtual ablation, but appear right away in simulations using models with different EP properties.

Conclusion
==========

In conclusion, we showed that perturbing APD and CV by ±10% caused relatively small variation in VT localization. In a small number of cases, new reentries at locations distinct from those in EP~avg~ emerged when EP parameters changed. Most of those were revealed in EP~avg~ models when the simulation protocol for determining the ablation targets was repeated with the initial targets incorporated in the models. Overall, the localization of the induced VTs was primarily driven by the remodeled structural substrate. Thus, personalized ventricular modeling with an average representation of infarct-remodeled EP may uncover most targets for VT ablation.

Limitations
===========

The first limitation is that we only considered a relatively limited subset of the parameter space of four discrete changes (±10% APD and ±10% CV). Considering the relatively low CV and long APD in GZ used in our model, further changes in these parameters will make these values fall out of the experimental range. Furthermore, we conducted a large number of simulations with 25 different 3D LV models. The sheer amount of computational time makes exploration of additional ranges of parameter values technically difficult. The second limitation in this study is that in order to achieve different APD values, we only changed I~Kr~ and I~Ks~ currents in our single cell models. We did not alter the Ca current as it would not only affect APD restitution, but would also have impact on other single cell properties and thus making the organ scale modeling too complicated to analyze. Furthermore, as the goal of this study was to provide a sensitivity analysis of ablation targeting, we did not explore the mechanisms of all the observed phenomena, including arrhythmogenesis arising from locally reduced APD. Finally, our model did not consider the influence of Purkinje system, the role of the right ventricle, and potential alterations in fiber orientation that cannot be captures by our patient-specific rule-based approach.
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